Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lund

Showing results (731-740 of 826) with videos related to

Pageof 83
Sort By:
European Journal of Heart Failure|December 22, 2019
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term RegistryMitja Lainščak, Ivan Milinković, Marija Polovina, et al.
FEBS Letters|March 22, 2024
EU-LIFE charter of independent life science research institutesGiulio Superti-Furga, Marta Agostinho, Jo Bury, et al.
European Journal of Heart Failure|April 28, 2023
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC-HFA EORP Heart Failure Long-Term RegistryAgnieszka Kapłon-Cieślicka, Lina Benson, Ovidiu Chioncel, et al.
European Journal of Heart Failure|March 12, 2025
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of CardiologyMaurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, et al.
Scientific Reports|October 20, 2023
Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemicPiotr Gajewski, Mikołaj Błaziak, Szymon Urban, et al.
European Heart Journal|February 25, 2026
Outcomes of heart failure with reduced, mildly reduced, or preserved ejection fraction: the ESC HF III registryLars H Lund, Aldo P Maggioni, Maria G Crespo-Leiro, et al.
Annals of Internal Medicine|June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized TrialMichael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular DiseasesGianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
European Journal of Heart Failure|June 28, 2019
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Tobias König, Peter van der Meer, et al.
Circulation|November 19, 2019
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart FailureScott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 83

Showing results (731-740 of 826) with videos related to

Sort By:
Pageof 83
European Journal of Heart Failure|December 22, 2019
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term RegistryMitja Lainščak, Ivan Milinković, Marija Polovina, et al.
FEBS Letters|March 22, 2024
EU-LIFE charter of independent life science research institutesGiulio Superti-Furga, Marta Agostinho, Jo Bury, et al.
European Journal of Heart Failure|April 28, 2023
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC-HFA EORP Heart Failure Long-Term RegistryAgnieszka Kapłon-Cieślicka, Lina Benson, Ovidiu Chioncel, et al.
European Journal of Heart Failure|March 12, 2025
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of CardiologyMaurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, et al.
Scientific Reports|October 20, 2023
Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemicPiotr Gajewski, Mikołaj Błaziak, Szymon Urban, et al.
European Heart Journal|February 25, 2026
Outcomes of heart failure with reduced, mildly reduced, or preserved ejection fraction: the ESC HF III registryLars H Lund, Aldo P Maggioni, Maria G Crespo-Leiro, et al.
Annals of Internal Medicine|June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized TrialMichael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular DiseasesGianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
European Journal of Heart Failure|June 28, 2019
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Tobias König, Peter van der Meer, et al.
Circulation|November 19, 2019
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart FailureScott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.
Pageof 83